Controlled development and manufacture of liposomal systems for commercial-scale
GMPriority Pharma provides contract manufacturing for liposomal formulations, supporting partners from process definition through to commercial-scale batch production.
Operating within GMP-certified, FSSC ISO 22000-accredited UK facilities, we align formulation, processing and manufacturing conditions to ensure consistent, scalable output.
Successful liposomal products depend not only on formulation design, but on how those systems are translated into controlled manufacturing processes.
GMPriority Pharma structures contract manufacturing programmes to ensure alignment between:
GMPriority Pharma delivers contract manufacturing programmes through a defined integrated model spanning development, scale-up and commercial production.
Rather than separating formulation and manufacture, our approach ensures systems are designed, evaluated and produced within controlled operational frameworks from the outset.
GMPriority Pharma addresses this by:
This ensures smoother transition from development into commercial production, reducing the need for reformulation.
Contract manufacturing is suited to:
GMPriority Pharma’s white label programmes provide a structured, controlled route to market, combining delivery science, manufacturing discipline and commercial readiness.
Finished products are developed with commercial manufacture in mind from the outset.
GMPriority Pharma focuses on formulation robustness, process transfer and batch-to-batch consistency, delivering products which can be manufactured reliably as volumes grow.
We support:
This is particularly important for partners operating within regulated or quality-sensitive markets.
Our objective is to establish controlled, repeatable liposomal manufacturing programmes aligned with partner requirements and regulatory frameworks.
Engagement typically begins with:
Technical review of formulation requirements
Assessment of compatibility with liposomal processing
Agreement and alignment of production expectations
Defined manufacturing and quality framework
GMPriority Pharma provides the structure, control and manufacturing capability required to translate liposomal formulations into reliable commercial products.